Recent Updates
Recently added Catalysts
DCGO Negative Sentiment

DocGo Announces Second Quarter 2026 Results

Monday, August 17, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: DocGo Inc. reported its financial results for the second quarter of 2026, revealing a revenue decline to $73.4 million from $80.4 million in the same quarter of 2025. The decrease in revenue was entirely due to the cessation of migrant-related programs, impacting overall financial performance. The company continues to focus on its mobile health and medical transportation services.
Price reaction · baseline $0.7101 (2026-08-17 close) · hit after-hours · clean, no other DCGO news in the window
day 0 close
-33.1%
day 1 · peak
-40.8%
day 3
-38.8%

Market Sentiment Analysis

CONCERNS & RISKS

  • Total revenue decreased from $80.4 million in Q2 2025 to $73.4 million in Q2 2026.
  • The revenue decline was attributed to the wind-down of migrant-related programs.

Full Press Release Details

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights Total revenue for the second quarter of 2026 was $73.4 million, compared to $80.4 million in the second quarter of 2025. This decline was entirely due to the wind-down of migrant-related progra

Frequently Asked Questions

What were DocGo's Q2 2026 total revenues?

DocGo reported total revenues of $73.4 million for Q2 2026.

How did Q2 2026 revenues compare to Q2 2025?

Revenues decreased from $80.4 million in Q2 2025 to $73.4 million in Q2 2026.

What caused the revenue decline for DocGo?

The revenue decline was attributed to the wind-down of migrant-related programs.

ShareAdd on Google
Tags: DCGO DocGo mobile health medical transportation financial results
Last updated: Aug 17, 2026

Biotech snapshot

Cash runway
$25M liquidity · $3M/mo burn
~6 mo
High dilution risk